125 related articles for article (PubMed ID: 14517841)
1. Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays.
Tannapfel A; Anhalt K; Häusermann P; Sommerer F; Benicke M; Uhlmann D; Witzigmann H; Hauss J; Wittekind C
J Pathol; 2003 Oct; 201(2):238-49. PubMed ID: 14517841
[TBL] [Abstract][Full Text] [Related]
2. Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas.
Weber A; Hengge UR; Stricker I; Tischoff I; Markwart A; Anhalt K; Dietz A; Wittekind C; Tannapfel A
Hum Pathol; 2007 Feb; 38(2):228-38. PubMed ID: 17020778
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor alpha (TNF)-TNF receptor 1-inducible cytoprotective proteins in the mouse liver: relevance of suppressors of cytokine signalling.
Sass G; Shembade ND; Tiegs G
Biochem J; 2005 Jan; 385(Pt 2):537-44. PubMed ID: 15554901
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
[TBL] [Abstract][Full Text] [Related]
5. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
6. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
[TBL] [Abstract][Full Text] [Related]
7. Identification of suppressors of cytokine signaling (SOCS) proteins in human gestational tissues: differential regulation is associated with the onset of labor.
Blumenstein M; Bowen-Shauver JM; Keelan JA; Mitchell MD
J Clin Endocrinol Metab; 2002 Mar; 87(3):1094-7. PubMed ID: 11889171
[TBL] [Abstract][Full Text] [Related]
8. SOCS proteins: negative regulators of cytokine signaling.
Krebs DL; Hilton DJ
Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
[TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
[TBL] [Abstract][Full Text] [Related]
10. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
[TBL] [Abstract][Full Text] [Related]
11. Suppressors of cytokine signalling (SOCS): putative modulators of cytokine bioactivity in health and disease.
Diamond P; Doran P; Brady HR; McGinty A
J Nephrol; 2000; 13(1):9-14. PubMed ID: 10720209
[TBL] [Abstract][Full Text] [Related]
12. The effect of burn injury on suppressors of cytokine signalling.
Ogle CK; Kong F; Guo X; Wells DA; Aosasa S; Noel G; Horseman N
Shock; 2000 Sep; 14(3):392-8; discussion 398-9. PubMed ID: 11028562
[TBL] [Abstract][Full Text] [Related]
13. Suppressor of cytokine signaling 1/JAB and suppressor of cytokine signaling 3/cytokine-inducible SH2 containing protein 3 negatively regulate the signal transducers and activators of transcription signaling pathway in normal human epidermal keratinocytes.
Yamasaki K; Hanakawa Y; Tokumaru S; Shirakata Y; Sayama K; Hanada T; Yoshimura A; Hashimoto K
J Invest Dermatol; 2003 Apr; 120(4):571-80. PubMed ID: 12648219
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions.
Mazzarella G; MacDonald TT; Salvati VM; Mulligan P; Pasquale L; Stefanile R; Lionetti P; Auricchio S; Pallone F; Troncone R; Monteleone G
Am J Pathol; 2003 Jun; 162(6):1845-55. PubMed ID: 12759242
[TBL] [Abstract][Full Text] [Related]
15. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
[TBL] [Abstract][Full Text] [Related]
16. Knocking the SOCS off a tumor suppressor.
Kishimoto T; Kikutani H
Nat Genet; 2001 May; 28(1):4-5. PubMed ID: 11326261
[No Abstract] [Full Text] [Related]
17. Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas.
Nagai H; Kim YS; Konishi N; Baba M; Kubota T; Yoshimura A; Emi M
Cancer Lett; 2002 Dec; 186(1):59-65. PubMed ID: 12183076
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.
Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM
Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.
Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K
J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990
[TBL] [Abstract][Full Text] [Related]
20. Expression of interferon alfa signaling components in human alcoholic liver disease.
Nguyen VA; Gao B
Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]